Patients with isolated prolonged in vitro bleeding time
Stein, M.; Scholz, K.; Llugaliu, B.; Asmelash, G.; Miesbach, W.; Alesci, S. · Zeitschrift für Orthopädie und Unfallchirurgie · 2011 · Heft S 01 · S. S64-S68
Bibliografische Angaben
Zusammenfassung
SummaryIn patients with isolated prolonged in vitro bleeding time there is no standardised treatment concept. With this study we characterized the extent of bleeding symptoms. Patients, methods All diagnoses known to cause prolonged in vitro bleeding time (PFA-100) (epinephrine-cartridge >160 s, ADP-cartridge > 120 s) have been excluded, such as platelet function disorders, effects of medications, nutrition or von Willebrand disease. 75 patients (77%, n = 58 women; 23%, n = 17 men, median age 46 (16–81) years were included. All bleeding symptoms have been stored in a databank with help of a comprehensive questio…
